A unique level of academic research + improved access to equity investment

=

How come Europe is still lacking bioentrepreneurs?

 

Should we learn from overseas? Boston, do we have a problem?

 

It looks like a rather egg-and-chicken problem:

  • Should we convince talented scientists to become entrepreneur?
  • Should we attract entrepreneurs towards Life Sciences?
  • Are we sure that the support of technology transfer offices, is sufficent ?
  • Do incubators provide  a wide enough network?

 

That is a subject as delicate as it is interesting, that we will be happy to debate with the plenary session dream team.

Moderated by no other man that John Hodgson, data Editor at Informa in UK, the entrepreneur point of view will be brought by one of the top 10 bioentrepreneurs under 30 in 2017, David Wehner, Managing Director of Venneos, DE. The VC point of view will be brought by Rafaèle Tordjman, Special Adviser at Sofinnova Partners, FR, who recently launched the vibrant network WITH Association. Our serial entrepreneur Alain Wagner, Director at the CNRS will address the ebbs and flows of entrepreneurship in the US while Valentin Lubbe will address the roots of the issue, as he is heading the Nordic Mentor Network for entrepreneurship of Denmark. Last but not least, Dick Hoogenberg, partner at EY will paint the background scene by settling the state of the market.

 

John Hodgson, Data Editor, Informa (UK)

David Wehner, Managing Director, Venneos (DE)

Rafaèle Tordjman, Special Adviser, Sofinnova Partners, FR)

Toby Reid, Managing Director, BioCity (UK)

Alain Wagner, Research Director and serial entrepreneur CNRS (FR)

Valentin Lubbe, Program Manager, Nordic Mentor Network for Entrepreneurship (DK)

Dick Hoogenberg, Partner, EY (NL)

 

Can’t wait to attend the session? So can’t we!

Be sure to join us 28th November from 11.30 am to 1.00 pm in Strasbourg

Want to join the team ? Contact Claire